{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:40:40Z","timestamp":1786621240709,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG3N0461-62"],"award-info":[{"award-number":["CMRPG3N0461-62"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPD1M0242"],"award-info":[{"award-number":["CMRPD1M0242"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 110-2314-B-182-029"],"award-info":[{"award-number":["MOST 110-2314-B-182-029"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-182A-085"],"award-info":[{"award-number":["NSTC 113-2314-B-182A-085"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2314-B-182A-119-MY3"],"award-info":[{"award-number":["114-2314-B-182A-119-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2314-B-182-074"],"award-info":[{"award-number":["113-2314-B-182-074"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2314-B-182-041-MY3"],"award-info":[{"award-number":["114-2314-B-182-041-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nucmedbio.2026.109642","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:35:28Z","timestamp":1780155328000},"page":"109642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating the tumour detection efficacy of [18F]Fluorthanatrace positron emission tomography in a metastatic lung cancer animal model"],"prefix":"10.1016","volume":"158-159","author":[{"given":"Chi-Chang","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Hsing","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faria","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiaoju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Han","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-2554","authenticated-orcid":false,"given":"Yi-Hsiu","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2026.109642_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1615\/CritRevEukaryotGeneExpr.2013006875","article-title":"Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases","volume":"24","author":"Morales","year":"2014","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.21037\/cco-23-58","article-title":"Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis","volume":"12","author":"Olivares-Hernandez","year":"2023","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0020","article-title":"[18F]FDG PET\/CT in the preoperative diagnostic and staging of lung cancer and as a predictor of lymph node involvement","volume":"14","author":"Viohl","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01243894-200601000-00014","article-title":"PET scan in lung cancer: current recommendations and innovation","volume":"1","author":"Vansteenkiste","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0030","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2214\/ajr.182.4.1820983","article-title":"False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities","volume":"182","author":"Asad","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0035","first-page":"94","article-title":"[18F]Fluorthanatrace uptake as a marker of PARP1 expression and activity in breast cancer","volume":"6","author":"Edmonds","year":"2016","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1148\/radiol.2016161929","article-title":"PET of poly(ADP-ribose) polymerase activity in cancer: preclinical assessment and first in-human studies","volume":"282","author":"Michel","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0045","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-10-245","article-title":"Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin","volume":"10","author":"Shiau","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0055","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/1573405616666201012154548","article-title":"Evaluation of the small-animal nano scan PET\/CT system using 89Zr","volume":"17","author":"Alzimami","year":"2021","journal-title":"Curr Med Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13010110","article-title":"Glycolytic plasticity of metastatic lung cancer captured by noninvasive [18F]FDG PET\/CT and serum 1H-NMR analysis: an orthotopic murine model study","volume":"13","author":"Chung","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0065","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3465","article-title":"Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol","volume":"9","author":"Crowe","year":"2019","journal-title":"Bio Protoc"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0070","doi-asserted-by":"crossref","first-page":"20.1.1","DOI":"10.1002\/0471142735.im2001s39","article-title":"B16 as a mouse model for human melanoma","volume":"39","author":"Overwijk","year":"2000","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0075","doi-asserted-by":"crossref","first-page":"13034","DOI":"10.1038\/s41598-022-17460-0","article-title":"[18F]-labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy response","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0080","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2967\/jnumed.118.213223","article-title":"PET imaging of PARP expression using (18)F-olaparib","volume":"60","author":"Wilson","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0085","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11307-015-0904-y","article-title":"Non-invasive PET imaging of PARP1 expression in glioblastoma models","volume":"18","author":"Carney","year":"2016","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0090","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1172\/JCI97992","article-title":"A PET imaging agent for evaluating PARP-1 expression in ovarian cancer","volume":"128","author":"Makvandi","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0095","doi-asserted-by":"crossref","first-page":"21068","DOI":"10.1038\/s41598-020-78273-7","article-title":"Intra-individual dynamic comparison of [18F]-PSMA-11 and [68Ga]-PSMA-11 in LNCaP xenograft bearing mice","volume":"10","author":"Piron","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nucmedbio.2020.05.006","article-title":"Immuno-SPECT\/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma","volume":"86","author":"Wen","year":"2020","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.athoracsur.2011.02.052","article-title":"Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease","volume":"92","author":"Deppen","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11307-018-1233-8","article-title":"Effects of a ketogenic diet on [18F]FDG-PET imaging in a mouse model of lung cancer","volume":"21","author":"Cuss\u00f3","year":"2019","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107999","article-title":"Comparison of methods to reduce myocardial [18F]FDG uptake in mice: calcium channel blockers versus high-fat diets","volume":"9","author":"Cusso","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0120","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/PGP.0000000000000310","article-title":"The prognostic value of BRCA1 and PARP expression in epithelial ovarian carcinoma: immunohistochemical detection","volume":"36","author":"Hjortkjaer","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0125","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1007\/s13277-015-4465-0","article-title":"Nuclear PARP1 expression and its prognostic significance in breast cancer patients","volume":"37","author":"Mazzotta","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0130","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.3892\/ol.2016.5169","article-title":"High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer","volume":"12","author":"Liu","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0135","article-title":"PARP1 is up-regulated in non-small cell lung cancer tissues in the presence of the cyanobacterial toxin microcystin","volume":"9 - 2018","author":"Apopa","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb0140","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1158\/1078-0432.CCR-22-1602","article-title":"[18F]Fluorthanatrace ([18F]FTT) PET imaging of PARP-inhibitor drug-target engagement as a biomarker of response in ovarian cancer, a pilot study","volume":"29","author":"Pantel","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb3005","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.3390\/curroncol30030239","article-title":"Stage III non-small-cell lung cancer: an overview of treatment options","volume":"30","author":"Petrella","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb3010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1615\/CritRevEukaryotGeneExpr.2013006875","article-title":"Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases","volume":"24","author":"Morales","year":"2014","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.nucmedbio.2026.109642_bb3015","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.bmc.2014.01.019","article-title":"Synthesis, [18F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography","volume":"22","author":"Zhou","year":"2014","journal-title":"Bioorg Med Chem"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:25:05Z","timestamp":1786620305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805126000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"alternative-id":["S0969805126000417"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109642","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the tumour detection efficacy of [18F]Fluorthanatrace positron emission tomography in a metastatic lung cancer animal model","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109642"}}